ESR1 and breast cancer: To investigate the nature of interaction between NAFs and ER+BCCs, we developed a 3-dimensional (3D) organoid model system initiated with primary malignant human ER+ breast cancer cells (ER+BCCs) and either stromal fibroblast obtained from the matching original tumors or breast reduction samples for up to 10 days (Figure 1A).